Vitamin D receptor gene silencing effects on differentiation of myogenic cell lines

Muscle and Nerve

Volumn 49, Issue 5, 2014, Pages 700-708

  Tanaka, Masahiko ^a   Kishimoto, Koshi N ^a   Okuno, Hiroshi ^a   Saito, Hideo ^a   Itoi, Eiji ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C2C12; G8; Gene silencing; Myoblasts; Myosin heavy chain; VDR

Indexed keywords

C2C12; G8; GENE SILENCING; MYOBLASTS; MYOSIN HEAVY CHAIN; VDR;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; GENE SILENCING; MICE; MUSCLE CELLS; MUSCLE DEVELOPMENT; MYOBLASTS; MYOGENIN; MYOSIN HEAVY CHAINS; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84898779463     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23950     Document Type: Article

References (26)

1. Rescan PY. Regulation and functions of myogenic regulatory factors in lower vertebrates. Comp Biochem Physiol B Biochem Mol Biol 2001;130:1-12.
2. Ritz E, Boland R, Kreusser W. Effects of vitamin D and parathyroid hormone on muscle: potential role in uremic myopathy. Am J Clin Nutr 1980;33:1522-1529.
3. Eastwood JB, Stamp TC, De Wardener HE, Bordier PJ, Arnaud CD. The effect of 25-hydroxy vitamin D3 in the osteomalacia of chronic renal failure. Clin Sci Mol Med 1977;52:499-508.
4. Suzuki T, Kwon J, Kim H, Shimada H, Yoshida Y, Iwasa H, et al. Low serum 25-hydroxyvitamin D levels associated with falls among Japanese community-dwelling elderly. J Bone Miner Res 2008;23:1309-1317.
5. Dukas L, Bischoff HA, Lindpaintner LS, Schacht E, Birkner-Binder D, Damm TN, et al. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc 2004;52:230-236.
6. Gallagher JC. The effects of calcitriol on falls and fractures and physical performance tests. J Steroid Biochem Mol Biol 2004;89-90:497-501.
7. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009;339:b3692.
8. Okuno H, Kishimoto KN, Hatori M, Itoi E. 1alpha, 25-Dihydroxyvitamin D3 enhances fast-myosin heavy chain expression in differentiated C2C12 myoblasts. Cell Biol Int 2012;36:441-447.
9. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-839.
10. Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1, 25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am 2010;39:255-269, table of contents.
11. Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, Stahelin HB, et al. In situ detection of 1, 25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001;33:19-24.
12. Demay M. Muscle: a nontraditional 1, 25-dihydroxyvitamin D target tissue exhibiting classic hormone-dependent vitamin D receptor actions. Endocrinology 2003;144:5135-5137.
13. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29:726-776.
14. Boland RL. VDR activation of intracellular signaling pathways in skeletal muscle. Mol Cell Endocrinol 2011;347:11-16.
15. Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN. 1, 25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 2011;152:2976-2986.
16. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997;16:391-396.
17. Zinser G, Packman K, Welsh J. Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development 2002;129:3067-3076.
18. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1, 25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-238.
19. Sakai Y, Kishimoto J, Demay MB. Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice. J Clin Invest 2001;107:961-966.
20. Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003;144:5138-5144.
21. van den Hoff MJ, Moorman AF, Lamers WH. Electroporation in 'intracellular' buffer increases cell survival. Nucleic Acids Res 1992;20:2902.
22. Jongen MJ, van der Vijgh WJ, Willems HJ, Netelenbos JC, Lips P. Simultaneous determination of 25-hydroxyvitamin D, 24, 25-dihydroxyvitamin D, and 1, 25-dihydroxyvitamin D in plasma or serum. Clin Chem 1981;27:1757-1760.
23. Breidenbach A, Schlumbohm C, Harmeyer J. Peculiarities of vitamin D and of the calcium and phosphate homeostatic system in horses. Vet Res 1998;29:173-186.
24. Tuschl T. Expanding small RNA interference. Nat Biotechnol 2002;20:446-448.
25. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993;75:1351-1359.
26. Pownall ME, Gustafsson MK, Emerson CP Jr. Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu Rev Cell Dev Biol 2002;18:747-783.